500 related articles for article (PubMed ID: 26315948)
1. Pharmacological Management of Opioid Use Disorder in Pregnant Women.
Wilder CM; Winhusen T
CNS Drugs; 2015 Aug; 29(8):625-36. PubMed ID: 26315948
[TBL] [Abstract][Full Text] [Related]
2. Use of naltrexone in treating opioid use disorder in pregnancy.
Towers CV; Katz E; Weitz B; Visconti K
Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
[TBL] [Abstract][Full Text] [Related]
3. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
Klaman SL; Isaacs K; Leopold A; Perpich J; Hayashi S; Vender J; Campopiano M; Jones HE
J Addict Med; 2017; 11(3):178-190. PubMed ID: 28406856
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
[TBL] [Abstract][Full Text] [Related]
5. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine and methadone for opioid addiction during pregnancy.
Mozurkewich EL; Rayburn WF
Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
[TBL] [Abstract][Full Text] [Related]
7. Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient.
Pan A; Zakowski M
Clin Obstet Gynecol; 2017 Jun; 60(2):447-458. PubMed ID: 28426507
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
[TBL] [Abstract][Full Text] [Related]
9. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
Johnson S; Martin PR
Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.
Lacroix I; Berrebi A; Garipuy D; Schmitt L; Hammou Y; Chaumerliac C; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
Eur J Clin Pharmacol; 2011 Oct; 67(10):1053-9. PubMed ID: 21538146
[TBL] [Abstract][Full Text] [Related]
11. Treatment of opioid dependence in the setting of pregnancy.
Young JL; Martin PR
Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment of opioid use disorder in pregnancy.
Rodriguez CE; Klie KA
Semin Perinatol; 2019 Apr; 43(3):141-148. PubMed ID: 30755340
[TBL] [Abstract][Full Text] [Related]
13. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
14. Methadone and buprenorphine for the management of opioid dependence in pregnancy.
Jones HE; Finnegan LP; Kaltenbach K
Drugs; 2012 Apr; 72(6):747-57. PubMed ID: 22512363
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder.
Kanervo MM; Tupola SJ; Nikkola EM; Rantakari KM; Kahila HK
Acta Obstet Gynecol Scand; 2023 Mar; 102(3):313-322. PubMed ID: 36562462
[TBL] [Abstract][Full Text] [Related]
16. Association of Maternal Buprenorphine or Methadone Dose with Fetal Growth Indices and Neonatal Abstinence Syndrome.
Coulson CC; Lorencz E; Rittenhouse K; Ramage M; Lorenz K; Galvin SL
Am J Perinatol; 2021 Jan; 38(1):28-36. PubMed ID: 31421639
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Perinatal Opioid Use Disorder.
Boyars L; Guille C
Obstet Gynecol Clin North Am; 2018 Sep; 45(3):511-524. PubMed ID: 30092925
[TBL] [Abstract][Full Text] [Related]
18. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
[TBL] [Abstract][Full Text] [Related]
19. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.
Pritham UA; Paul JA; Hayes MJ
J Obstet Gynecol Neonatal Nurs; 2012 Mar; 41(2):180-190. PubMed ID: 22375882
[TBL] [Abstract][Full Text] [Related]
20. Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma.
Holbrook AM
Am J Drug Alcohol Abuse; 2015; 41(5):371-3. PubMed ID: 26154531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
